Harding Loevner’s AbbVie ABBV Stock Holding History

Harding Loevner’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$110M	Buy	592,388 +9,833	+2%	+$1.83M	0.74%	43
2025 Q1	$122M	Sell	582,555 -107,767	-16%	-$22.6M	0.93%	33
2024 Q4	$123M	Sell	690,322 -140,658	-17%	-$25M	0.83%	41
2024 Q3	$164M	Sell	830,980 -21,043	-2%	-$4.16M	0.95%	41
2024 Q2	$146M	Sell	852,023 -26,217	-3%	-$4.5M	0.81%	47
2024 Q1	$160M	Sell	878,240 -76,397	-8%	-$13.9M	0.99%	40
2023 Q4	$148M	Sell	954,637 -13,719	-1%	-$2.13M	0.83%	49
2023 Q3	$144M	Buy	968,356 +120,463	+14%	+$18M	0.95%	43
2023 Q2	$114M	Sell	847,893 -159,424	-16%	-$21.5M	0.67%	52
2023 Q1	$161M	Buy	+1,007,317	New	+$161M	0.91%	47
2022 Q4	–	Sell	-637	Closed	-$85K	–	84
2022 Q3	$85K	Hold	637	–	–	﹤0.01%	88
2022 Q2	$98K	Hold	637	–	–	﹤0.01%	87
2022 Q1	$96K	Sell	637 -210	-25%	-$31.6K	﹤0.01%	86
2021 Q4	$115K	Hold	847	–	–	﹤0.01%	90
2021 Q3	$91K	Hold	847	–	–	﹤0.01%	86
2021 Q2	$95K	Hold	847	–	–	﹤0.01%	88
2021 Q1	$92K	Buy	847 +515	+155%	+$55.9K	﹤0.01%	93
2020 Q4	$36K	Hold	332	–	–	﹤0.01%	118
2020 Q3	$29K	Buy	332 +180	+118%	+$15.7K	﹤0.01%	151
2020 Q2	$15K	Hold	152	–	–	﹤0.01%	126
2020 Q1	$12K	Buy	+152	New	+$12K	﹤0.01%	130
2016 Q4	–	Sell	-2,207,008	Closed	-$139M	–	75
2016 Q3	$139M	Sell	2,207,008 -8,611	-0.4%	-$543K	1%	41
2016 Q2	$137M	Buy	2,215,619 +10,317	+0.5%	+$639K	1.07%	37
2016 Q1	$126M	Sell	2,205,302 -56,200	-2%	-$3.21M	0.99%	43
2015 Q4	$134M	Sell	2,261,502 -318,953	-12%	-$18.9M	1.08%	39
2015 Q3	$140M	Sell	2,580,455 -153,460	-6%	-$8.35M	1.13%	37
2015 Q2	$186M	Buy	2,733,915 +74,350	+3%	+$5.07M	1.31%	27
2015 Q1	$156M	Buy	2,659,565 +24,250	+0.9%	+$1.42M	1.19%	32
2014 Q4	$172M	Sell	2,635,315 -363,435	-12%	-$23.8M	1.39%	28
2014 Q3	$173M	Buy	+2,998,750	New	+$173M	1.28%	33